课题基金 / 基金详情

Effects of ozone on CFTR expression and HIF signaling

Effects of ozone on CFTR expression and HIF signaling
臭氧对 CFTR 表达和 HIF 信号传导的影响
批准号:
7261862
负责人:
Jennifer S Guimbellot
金额:
$3.31万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-15 至 2009-07-14

项目摘要

项目成果

Jennifer S Guimbellot的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Many chronic lung diseases are caused or exacerbated by environmental factors such as cigarette smoke (chronic obstructive pulmonary disease) and air pollutants including ozone. The lung epithelia provides a first line defense against many of these agents. The cystic fibrosis transmembrane conductance regulator (CFTR) serves a pivotal role in normal epithelial homeostasis, including the maintenance of normal glutathione levels in the epithelial lining fluid (ELF), a critical component of the defense against airborne toxins. In chronic lung conditions, the activation of HIP signaling pathways, such as may be caused by tissue hypoxemia, result in the down-regulation of CFTR mRNA and protein levels (as suggested by studies in cell culture and mice). Reactive oxygen species, such as those produced by ozone exposure in the lung, have been shown to activate HIF signaling pathways. CFTR deficiency results in a significantly decreased level of glutathione in the ELF, predisposing the lung to oxidant/antioxidant imbalance and additional injury from environmental toxins. The repression of CFTR by HIF signaling pathways, activated by both hypoxia and ROS from pollutants like ozone, represents a novel mechanism for lung disease pathogenesis. The goals of this proposal are to investigate 1) the specific effects of ozone on HIF signaling and CFTR expression and function and 2) the molecular mechanisms by which ROS- and hypoxia-induced HIF signaling repress CFTR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pharmacometric approaches to precision optimization of ivacaftor response in cystic fibrosis patients
Pharmacometric approaches to precision optimization of ivacaftor response in cystic fibrosis patients
Pharmacometric approaches to precision optimization of ivacaftor response in cystic fibrosis patients
Effects of ozone on CFTR expression and HIF signaling
海外基金